J&J seeks wider use of its Spravato antidepressant in US

NS Pharma steals a march on Sarepta with DMD drug

FDA rejection scuppers AZ’s hopes of a COPD triple clash wit...

The FDA has just handed an advantage to GlaxoSmithKline’s triple therapy for chronic obstructive pulmonary disease (COPD) by

AveXis rules out EU compassionate use of SMA gene therapy, s...

Novartis’ AveXis unit has given its reasons for refusing to supply its spinal muscular atrophy gene therapy Zolgensma to a seriously ill child in Belgium, saying compassionate use rules do

Blow to Novartis as NICE rejects migraine drug Aimovig again

MHRA says Avastin can be used for AMD despite Bayer, Novarti...